Assignee
modeRNA Therapeutics
US·6 granted patents·8 pending applications·931 citations·filing 2012–2013
Top patents by PatentIndex Score
14 records- 0199US9186372B2Split dose administrationmodeRNA Therapeutics·Filed 2013·Granted Nov 17, 2015·86 cites·9 claims
- 0298US9428535B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofmodeRNA Therapeutics·Filed 2012·Granted Aug 30, 2016·113 cites·25 claims
- 0398US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 0498US8680069B2Modified polynucleotides for the production of G-CSFmodeRNA Therapeutics·Filed 2013·Granted Mar 25, 2014·180 cites·16 claims
- 0598US8664194B2Method for producing a protein of interest in a primatemodeRNA Therapeutics·Filed 2013·Granted Mar 4, 2014·90 cites·11 claims
- 0697US8754062B2DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotidesmodeRNA Therapeutics·Filed 2013·Granted Jun 17, 2014·204 cites·7 claims
- 0766US2013245103A1Modified polynucleotides for the production of factor ixmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 0866US2013266640A1Modified nucleoside, nucleotide, and nucleic acid compositionsmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 0966US2013245107A1Dlin-mc3-dma lipid nanoparticle delivery of modified polynucleotidesmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 1066US2013244282A1Method of producing antibodiesmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 1164US2013123481A1Modified nucleosides, nucleotides, and nucleic acids, and uses thereofmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 1264US2013156849A1Modified nucleoside, nucleotide, and nucleic acid compositionsmodeRNA Therapeutics·Filed 2012·Application pending·0 cites
- 1355US2013165504A1Methods of increasing the viability or longevity of an organ or organ explantmodeRNA Therapeutics·Filed 2012·Application pending·0 cites
- 1448US2014206752A1Engineered nucleic acids and methods of use thereof for non-human vertebratesmodeRNA Therapeutics·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →